Researchers at the Mayo Clinic College of Medicine and Science, who developed the technique, tested it on 92 patients with thyroid tumors, finding that the method could distinguish if the growths were cancerous with 89% accuracy. We understand our clients’ needs and work with them to deliver tangible benefits and peace of mind.The method-deemed high-definition microvasculature imaging, or HDMI-noninvasively captures images of the tiny vessels within tumors and, based on the vessel features, automatically classifies the masses. Today our ambition is not only to pursue the development of SFRI activities but also to continue to answer our clients growing needs by keeping up with technological advancements and providing them with ever more efficient and complete diagnostic solutions.Īt SFRI, we base our business relationships on mutual understanding and respect, high professional standards and integrity. SFRI is proud to provide accessible and affordable products and services of outstanding quality and reliability that contribute to bettering the quality of life of patients and the performance of medical professionals worldwide. Since its creation in 1977, SFRI has built up over 40 years of in-depth experience and expertise in the IVD field, specializing in human biological analysis and concentrating on routine clinical testing in the hematology, biochemistry and immunology sectors. SFRI is a French manufacturer and international exporter of In Vitro Diagnostic instruments and reagents present in over 100 countries around the world.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |